Development of Pseudomembranous Colitis Four Months after Initiation of Rifampicin
Open Access
- 1 January 2011
- journal article
- Published by S. Karger AG in Case Reports in Gastroenterology
- Vol. 5 (1) , 45-51
- https://doi.org/10.1159/000323753
Abstract
Pseudomembranous colitis (PMC) may develop with long-term antibiotic administration, but is rarely reported to be caused by antitubercular agents. We present a case of PMC that occurred 120 days after starting rifampicin. A 74-year-old man was diagnosed with pulmonary tuberculosis and started on a standard HERZ regimen (isoniazid, ethambutol, rifampicin, pyrazinamide). After 4 months of HERZ, he presented with frequent bloody, mucoid, jelly-like diarrhea and lower abdominal pain. Sigmoidoscopy revealed multiple whitish plaques with edematous mucosa that were compatible with PMC. Biopsies from these lesions showed ulcer-related necrotic and granulation tissue. We stopped antitubercular treatment and started the patient on oral metronidazole. His symptoms completely resolved within 2 weeks. Antitubercular treatment was restarted by replacing rifampicin with levofloxacin. The patient did not present with diarrhea or bloody stool throughout the rest of treatment.Keywords
This publication has 11 references indexed in Scilit:
- Clinical Aspects of Rifampicin-associated Pseudomembranous ColitisJournal of Clinical Gastroenterology, 2007
- Rifampicin-associated pseudomembranous colitis.The Esophagus, 2000
- Antimicrobial Susceptibilities and Serogroups of Clinical Strains of Clostridium difficile Isolated in France in 1991 and 1997Antimicrobial Agents and Chemotherapy, 1999
- Pseudomembranous Colitis: Causes and CuresDigestion, 1999
- Clostridium difficile ColitisNew England Journal of Medicine, 1994
- Pseudomembranous ColitisNew England Journal of Medicine, 1992
- PSEUDOMEMBRANOUS COLITIS DUE TO RIFAMPICINThe Lancet, 1981
- Pseudomembranous Colitis and RifampicinChest, 1981
- Rifampicin-associated pseudomembranous colitis.BMJ, 1980
- PSEUDOMEMBRANOUS COLITIS PROBABLY DUE TO RIFAMPICINThe Lancet, 1980